The estimated Net Worth of Robert D. Reed is at least $4.33 Milion dollars as of 12 November 2021. Mr. Reed owns over 5,940 units of Ventas Inc stock worth over $4,020,800 and over the last 17 years he sold VTR stock worth over $0. In addition, he makes $308,728 as Independent Director at Ventas Inc.
Robert has made over 4 trades of the Ventas Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 5,940 units of VTR stock worth $275,675 on 12 November 2021.
The largest trade he's ever made was exercising 5,940 units of Ventas Inc stock on 12 November 2021 worth over $275,675. On average, Robert trades about 253 units every 12 days since 2008. As of 12 November 2021 he still owns at least 61,546 units of Ventas Inc stock.
You can see the complete history of Mr. Reed stock trades at the bottom of the page.
Robert D. Reed serves as Independent Director of the Company. Mr. Reed was Senior Vice President and Chief Financial Officer of Sutter Health, a family of not-for-profit hospitals and physicians organizations in northern California, until his retirement on January 1, 2015. Prior to that, he held various finance positions within Sutter Health and its affiliates. Before he became a hospital system executive, Mr. Reed was an investment banker specializing in healthcare finance for hospital systems at various national financial firms, including Eastdil, Paine Webber and American Health Capital. Mr. Reed presently serves on the board of Metta Fund, a private non-profit foundation.
As the Independent Director of Ventas Inc, the total compensation of Robert Reed at Ventas Inc is $308,728. There are 14 executives at Ventas Inc getting paid more, with Debra Cafaro having the highest compensation of $11,348,300.
Robert Reed is 67, he's been the Independent Director of Ventas Inc since 2008. There are 1 older and 18 younger executives at Ventas Inc. The oldest executive at Ventas Inc is Richard Gilchrist, 74, who is the Independent Director.
Robert's mailing address filed with the SEC is 353 N. CLARK STREET, SUITE 3300, CHICAGO, IL, 60654.
Over the last 20 years, insiders at Ventas Inc have traded over $3,514,800,086 worth of Ventas Inc stock and bought 14,500 units worth $790,035 . The most active insiders traders include Holdings Llc Lazard Alterna..., Matthew J Lustig a Senior Quarters Llc Lazard .... On average, Ventas Inc executives and independent directors trade stock every 24 days with the average trade being worth of $15,339,027. The most recent stock trade was executed by Peter J. Bulgarelli on 10 September 2024, trading 7,500 units of VTR stock currently worth $487,875.
celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co
Ventas Inc executives and other stock owners filed with the SEC include: